ArticleInternational journal of clinical pharmacy2024

Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years.

E Pons-Fuster et al.PubMed ↗Publisher ↗

No numbers read from the abstract.